U.S. FDA advisers back MannKind's inhaled diabetes drug
HYATTSVILLE, Maryland (Reuters) - U.S. health advisers on Tuesday recommended approval of MannKind Corp's inhaled diabetes drug, and said the experime...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/58PrnAKqNhg/story01.htm
No comments:
Post a Comment